rs117070973

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_182914.3(SYNE2):​c.17561T>C​(p.Leu5854Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00638 in 1,614,206 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L5854I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0051 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0065 ( 53 hom. )

Consequence

SYNE2
NM_182914.3 missense

Scores

5
8
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 4.39

Publications

10 publications found
Variant links:
Genes affected
SYNE2 (HGNC:17084): (spectrin repeat containing nuclear envelope protein 2) The protein encoded by this gene is a nuclear outer membrane protein that binds cytoplasmic F-actin. This binding tethers the nucleus to the cytoskeleton and aids in the maintenance of the structural integrity of the nucleus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
ESR2 (HGNC:3468): (estrogen receptor 2) This gene encodes a member of the family of estrogen receptors and superfamily of nuclear receptor transcription factors. The gene product contains an N-terminal DNA binding domain and C-terminal ligand binding domain and is localized to the nucleus, cytoplasm, and mitochondria. Upon binding to 17beta-estradiol or related ligands, the encoded protein forms homo- or hetero-dimers that interact with specific DNA sequences to activate transcription. Some isoforms dominantly inhibit the activity of other estrogen receptor family members. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been fully characterized. [provided by RefSeq, Jul 2008]
ESR2 Gene-Disease associations (from GenCC):
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ovarian dysgenesis 8
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008620858).
BP6
Variant 14-64186428-T-C is Benign according to our data. Variant chr14-64186428-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 199247.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00505 (770/152342) while in subpopulation NFE AF = 0.00817 (556/68028). AF 95% confidence interval is 0.00761. There are 3 homozygotes in GnomAd4. There are 397 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 770 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE2NM_182914.3 linkc.17561T>C p.Leu5854Pro missense_variant Exon 97 of 116 ENST00000555002.6 NP_878918.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE2ENST00000555002.6 linkc.17561T>C p.Leu5854Pro missense_variant Exon 97 of 116 1 NM_182914.3 ENSP00000450831.2 Q8WXH0-2A0A0C4DGK3

Frequencies

GnomAD3 genomes
AF:
0.00506
AC:
770
AN:
152224
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00923
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00817
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00515
AC:
1296
AN:
251496
AF XY:
0.00507
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00153
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0104
Gnomad NFE exome
AF:
0.00773
Gnomad OTH exome
AF:
0.00456
GnomAD4 exome
AF:
0.00651
AC:
9524
AN:
1461864
Hom.:
53
Cov.:
32
AF XY:
0.00636
AC XY:
4622
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.000986
AC:
33
AN:
33480
American (AMR)
AF:
0.00181
AC:
81
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000650
AC:
17
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00270
AC:
233
AN:
86256
European-Finnish (FIN)
AF:
0.00983
AC:
525
AN:
53416
Middle Eastern (MID)
AF:
0.00277
AC:
16
AN:
5768
European-Non Finnish (NFE)
AF:
0.00749
AC:
8325
AN:
1111996
Other (OTH)
AF:
0.00487
AC:
294
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
575
1151
1726
2302
2877
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
310
620
930
1240
1550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00505
AC:
770
AN:
152342
Hom.:
3
Cov.:
32
AF XY:
0.00533
AC XY:
397
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.00113
AC:
47
AN:
41578
American (AMR)
AF:
0.00340
AC:
52
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4826
European-Finnish (FIN)
AF:
0.00923
AC:
98
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00817
AC:
556
AN:
68028
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
42
84
127
169
211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00623
Hom.:
7
Bravo
AF:
0.00388
TwinsUK
AF:
0.00836
AC:
31
ALSPAC
AF:
0.0117
AC:
45
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00605
AC:
52
ExAC
AF:
0.00574
AC:
697
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00583
EpiControl
AF:
0.00658

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SYNE2: BS2 -

Sep 14, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Emery-Dreifuss muscular dystrophy 5, autosomal dominant Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Oct 06, 2016
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Feb 27, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.59
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Uncertain
0.020
CADD
Benign
23
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.60
.;D;T
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.60
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Benign
0.84
T;T;T
MetaRNN
Benign
0.0086
T;T;T
MetaSVM
Benign
-0.50
T
MutationAssessor
Pathogenic
3.0
M;M;.
PhyloP100
4.4
PrimateAI
Uncertain
0.55
T
PROVEAN
Pathogenic
-6.3
D;D;D
REVEL
Uncertain
0.35
Sift
Pathogenic
0.0
D;D;D
Sift4G
Uncertain
0.0030
D;D;D
Polyphen
0.99
D;D;.
Vest4
0.85
MVP
0.63
MPC
0.39
ClinPred
0.034
T
GERP RS
5.7
Varity_R
0.91
gMVP
0.70
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117070973; hg19: chr14-64653146; COSMIC: COSV59951050; API